SCHEMBL10050812

SCHEMBL10050812

CC(C)(C)C1C=CC=N1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8550028 0.72
SCHEMBL18474376 0.67
SCHEMBL13077862 0.65
SCHEMBL24511041 0.61
SCHEMBL873618 0.61
SCHEMBL16420300 0.60
SCHEMBL9977690 0.59
SCHEMBL24061655 0.59
SCHEMBL14076040 0.59
Benzene SCHEMBL29202409 0.57

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10251831-B2 Extract for treating wrinkles and/or fine lines AVON PRODUCTS, INC. (US) 2019-04-09 US disclosed
US-20180051041-A1 BORONIC ACID DERIVATIVES AND THERAPEUTIC USES THEREOF THE MEDICINES COMPANY (SAN DIEGO), LLC 2018-02-22 US disclosed
US-20170135926-A1 TOPICAL COMPOSITIONS AND METHODS FOR SKIN LIGHTENING AVON PROD INC (US) 2017-05-18 US disclosed
US-20170135926-A1 TOPICAL COMPOSITIONS AND METHODS FOR SKIN LIGHTENING AVON PROD INC (US) 2017-05-18 US disclosed
US-9592186-B2 Topical compositions and methods for skin lightening AVON PRODUCTS, INC. (US) 2017-03-14 US disclosed
US-9592186-B2 Topical compositions and methods for skin lightening AVON PRODUCTS, INC. (US) 2017-03-14 US disclosed
US-9566224-B2 Tyrosinase inhibitors AVON PRODUCTS, INC. (US) 2017-02-14 US disclosed
US-20160263006-A1 TOPICAL COMPOSITIONS AND METHODS FOR SKIN LIGHTENING AVON PRODUCTS, INC. 2016-09-15 US disclosed
US-9364405-B2 Tyrosinase inhibitors AVON PRODUCTS, INC. (US) 2016-06-14 US disclosed
US-9289364-B2 Tyrosinase inhibitors AVON PRODUCTS, INC. (US) 2016-03-22 US disclosed
US-20150174034-A1 TYROSINASE INHIBITORS AVON PRODUCTS, INC. 2015-06-25 US disclosed
US-20150164758-A1 TYROSINASE INHIBITORS CITIBANK, N.A., LONDON BRANCH 2015-06-18 US disclosed
US-20150152122-A1 TYROSINASE INHIBITORS AVON PRODUCTS, INC. 2015-06-04 US disclosed
US-20150118170-A1 TYROSINASE INHIBITORS AVON PRODUCTS, INC. 2015-04-30 US disclosed
US-20150111897-A1 TYROSINASE INHIBITORS NEW AVON LLC 2015-04-23 US disclosed
US-8394427-B2 Paxillin stimulating compositions and cosmetic uses thereof AVON PRODUCTS, INC. (US) 2013-03-12 US disclosed
US-20120328546-A1 Paxillin Stimulating Compositions and Cosmetic Uses Thereof AVON PRODUCTS, INC. (US) 2012-12-27 US disclosed
US-8168212-B2 Topical compositions comprising non-proteogenic amino acids and methods of treating skin AVON PRODUCTS, INC (US) 2012-05-01 US disclosed
US-20110151029-A1 Paxillin Stimulating Compositions and Cosmetic Uses Thereof AVON PRODUCTS, INC. (US) 2011-06-23 US disclosed
US-20100261769-A1 Topical Compositions Comprising Non-Proteogenic Amino Acids and Methods of Treating Skin AVON PRODUCTS, INC. (US) 2010-10-14 US disclosed